medicare coverage of glp 1 drugs cuts cost popular GLP-1 weight-loss for eligible seniors Medicare GLP-1 Bridge Program 2026:

The Asia Pacific region is poised to witness the fastest growth over the forecast period

DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other

Other diabetes or weight-loss services that are covered via the respondents extended health plans include: Other prescription/non-GLP-1 drugs56% Nutritional counseling51% Telehealth/virtual care for lifestyle interventions30% Disease management programs/case management29% Telehealth/virtual care for GLP-1 drug treatment17% Lifestyle modification programs12% Bariatric surgery5%

Wraparound support New therapies for weight loss mean more choice for patients, eventually resulting in lower prices and more personalised approaches

All Major GLP-1 Drugs at a Glance Here is a side-by-side comparison of the most widely used GLP-1 and GLP-1/GIP drugs currently available in the United States: Note: Average weight loss figures are from landmark clinical trials and represent outcomes achieved with lifestyle support

By Therapeutic Area The market is also segmented by therapeutic area into Type 2 Diabetes Mellitus and obesity management